Concord Drugs Balance Sheet Annual

BSE: 538965 | NSE: - | ISIN: INE858L01010 | Sector: Biotechnology & Drugs

34.75 -1.25 (-3.47%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.18	0.10	0.07	0.06
Short Term Investments	0.05	0.14	0.10	0.04
Cashand Short Term Investments	0.22	0.24	0.17	0.10
Accounts Receivable- Trade Net	19.83	15.81	22.86	20.73
Total Receivables Net	19.83	15.81	22.86	20.73
Total Inventory	22.92	20.06	17.49	11.87
Other Current Assets Total	1.64	7.34	1.38	3.32
Total Current Assets	44.62	43.46	41.89	36.03
Property/ Plant/ Equipment Total- Net	12.67	13.20	13.88	13.19
Long Term Investments	1.48	1.53	0.64	0.64
Note Receivable- Long Term	0.04	0.04	0.03	0.03
Total Assets	58.81	58.23	56.45	49.88
Accounts Payable	3.44	5.27	7.18	3.15
Current Portof LT Debt/ Capital Leases	16.87	15.05	13.95	9.22
Other Currentliabilities Total	1.03	1.29	1.73	3.87
Total Current Liabilities	21.34	21.61	22.86	16.24
Long Term Debt	0.65	1.91	2.48	3.75
Total Long Term Debt	0.65	1.91	2.48	3.75
Total Debt	17.52	16.96	16.43	12.97
Deferred Income Tax	0.47	0.54	0.66	0.68
Other Liabilities Total	2.53	2.46	2.08	2.45
Total Liabilities	24.99	26.53	28.08	23.12
Common Stock Total	10.00	9.32	8.74	8.74
Retained Earnings( Accumulated Deficit)	23.82	22.39	19.62	18.02
Total Equity	33.82	31.70	28.36	26.77
Total Liabilities Shareholders' Equity	58.81	58.23	56.45	49.88
Total Common Shares Outstanding	1.00	0.93	0.87	0.87
Tangible Book Valueper Share Common Eq	33.82	34.03	32.44	30.61
Other Long Term Assets Total	-	0.00	-	-
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
Other Equity Total	-	0.00	-	-